Editor's letter

Welcome to the latest issue of Pharmaceutical Technology Focus magazine

In this issue, we report on the evolving story around drug shortages. The cover story investigates how recent quality issues and an increasingly limited generic drug manufacturing landscape have aggravated shortages, especially for cancer drugs. This has led to clinicians adopting rationing strategies. This issue’s big interview further delves into strategies to manage medical care in the midst of these shortages.

Also this month, we use data to explore how market access to drugs for rare diseases differs across the world. Nonprofits, which facilitate access, and each country’s unique drug reimbursement framework, dictate how soon patients can access these highly specialized and expensive therapies.

Don’t miss the special thematic supplement on how artificial intelligence tools are being used in the pharma and healthcare sector. All this, with the latest news, analysis and data on the pharmaceutical and biotech industry.

Manasi Vaidya, editor